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 Meesmann’s corneal dystrophy (MCD), a bilaterally sym-
metric disorder, is characterized by fragility of the corneal epi-
thelium [1,2]. MCD exhibits myriads of fine punctate opaci-
ties and cysts in the epithelium and occasionally in Bowman
membrane and can be diagnosed on slit-lamp examination.
While early disease is often asymptomatic, multiplication of
the cysts throughout late adolescence and adulthood can cause
epithelial erosion, leading to lacrimation, photophobia, and
pain. In most cases, visual acuity is rarely affected; however,
subepithelial scarring can occasionally produce irregular astig-
matism and irrevocable visual deficits. Light microscopy of-
ten shows a thickened basement membrane and electron mi-
croscopy will reveal affected corneal epithelial cells with
highly characteristic intracytoplasmic cysts containing an elec-
tron dense material referred to as “peculiar” substance [2,3].
The structural integrity of corneal epithelial cells derives
largely from its composition of cytoskeletal intermediate fila-
ments, specifically keratin 3 and keratin 12 [4,5]. These mol-
ecules function as heterodimers of type I and type II keratin
[6], whereby disruption of a single keratin polymer can com-
promise epithelial structure and function [7]. Until the present
study, 14 mutations in KRT12 and two mutations in KRT3 had
been found in MCD patients. All mutations were located in
either helix-initiation or helix-termination motif [8-17]. The
motifs were highly conserved among keratin proteins, and the
domains are important in intermediate filament assembly and
are likely involved in mediating end-to-end interactions be-
tween keratin heterodimers. Interestingly, there were more
mutations reported in the helix-initiation motif than in the he-
lix-termination motif of these two keratin genes. For example,
10 different mutations have been identified thus far in the he-
lix-initiation motif of KRT12, including substitution of amino
acid M129T [8], Q130P [9], N133K [10], R135S [11], R135G
[12], R135I [12], R135T [13], A137P [14], L140R [12], and
V143L [13]. However, there have been only four mutations
reported in the helix-termination motif in KRT12: I426V [15],
I426S [16], Y429D [12], and Y429C [17]. Also, the two re-
ported mutations in KRT3 (R503P [17], E509K [13]) are in
the helix-termination motif and not the helix-initiation motif.
In this paper, we report a new case of MCD found in a
family who exhibited severe spectrum of disease. We per-
formed mutation screening on the family and discovered a
novel missense mutation in the helix-termination motif of
KRT12.
METHODS
Subjects:  This study was approved by the institution review
board of the University of Texas Health Science Center at
Houston. All patients were informed about the study and signed
a consent form in accordance with guidelines set forth by the
Declaration of Helsinki. A large family with 17 members af-
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Purpose: To determine if a mutation within the coding region of the keratin 12 gene (KRT12) is responsible for a severe
form of Meesmann’s corneal dystrophy.
Methods: A family with clinically identified Meesmann’s corneal dystrophy was recruited and studied. Electron micros-
copy was performed on scrapings of corneal epithelial cells from the proband. Mutations in the KRT12 gene were sought
using direct genomic sequencing of leukocyte DNA from two affected and two unaffected family members. Subsequently,
the observed mutation was screened in all available family members using polymerase chain reaction and direct sequenc-
ing.
Results: A heterozygous missense mutation (Arg430Pro) was found in exon 6 of KRT12 in all 14 affected individuals
studied. Unaffected family members and 100 normal controls were negative for this mutation.
Conclusions: We have identified a novel mutation in the KRT12 gene that is associated with a symptomatic phenotype of
Meesmann’s corneal dystrophy. This mutation results in a substitution of proline for arginine in the helix termination
motif that may disrupt the normal helix, leading to a dramatic structural change of the keratin 12 protein.
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975fected with Meesmann’s corneal dystrophy was identified and
given complete eye exams. For detailed examination of pa-
tient corneas, bilateral corneal scrapings were performed on
the proband, and scrapings of corneal epithelial cells were sub-
sequently fixed in 2% glutaraldehyde and visualized by using
conventional electron microscopy.
Detection of KRT12 mutations: Genomic DNA was ex-
tracted from peripheral blood obtained from all family mem-
bers (Figure 1). Mutation screening of the KRT12 gene was
done initially in one affected and one unaffected family mem-
ber. The entire coding region (all eight exons) was examined
by direct polymerase chain reaction (PCR) sequencing. The
primers used for amplification of all exons of KRT12 are shown
in Table 1. PCR products were examined on 2% agarose gels
and then sequenced using an AB 3100 genetic analyzer (Ap-
plied Biosystems, Foster City, CA). A mutation in exon 6 was
confirmed by using the restriction enzyme FauI (New England
Biolabs, Beverly, MA), according to the manufacturer’s pro-
tocol, to digest PCR products from the proband and his unaf-
fected sister. Digested samples were run on 2.5% agarose gels,
and the bands were visualized by ethidium bromide staining.
Also, DNA samples from the remaining family members were
PCR amplified and sequenced for exon 6 of KRT12. The mu-
tation was further verified by sequencing of PCR products
amplified from 100 Centre d’Etude du Polymorphisme Humain
(CEPH) control samples.
RESULTS
Clinical Exam:  The proband was a 33-year-old male with
symptomatic MCD from birth. He presented with symptoms
of photophobia, lacrimation, periodic burning, and irritation.
He had flare-ups almost monthly that lasted from two days to
one week, followed by remission. Unlike most patients with
MCD, his visual acuity was significantly impaired (20/200
visual acuity score), and he wore corrective lenses. Slit-lamp
examination disclosed dense microcysts in the visual axis lim-
ited to the anterior epithelium in addition to significant ante-
rior basement membrane scarring (Figure 2). Clinical histo-
ries obtained from family members were remarkably similar.
The general impression by collective slit-lamp examinations
was consistent with MCD. In this family, however, MCD pre-
sents an unusually severe spectrum of disease.
Electron Microscopy:  Electron microscopy analysis of
the proband showed intraepithelial cysts involving the super-
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Figure 1. Pedigree of a large family with Meesmann’s corneal dystrophy showing a typical autosomal dominant mode of inheritance.  Squares
represent males and circles represent females. Filled symbols mark affected individuals. Individuals who contributed DNA samples and were
tested for the R430P mutation are marked with a plus sign. Asterisks denote participants who were clinically examined by the authors. Arrow
indicates the proband.
TABLE 1. PRIMERS FOR POLYMERASE CHAIN REACTION DIRECT SEQUENCING
Three different PCR products were used for sequence analysis of exon 1 since it was so large.
976ficial cell layers of the cornea. The cysts were bordered by
microvillous processes, indicating they were formed by acan-
tholysis (Figure 3). The cysts contained a “peculiar” substance
intermixed with numerous round vacuoles that were surround-
ing electron-dense elongated filamentous material [10].
Molecular Genetic Analysis:  Examination of phenotypes
within this five-generation family indicated an autosomal
dominant mode of inheritance (Figure 1). Since a majority of
MCD patients have mutations in KRT12, we hypothesized that
a mutation in KRT12 might be associated with the phenotype
observed in this family. To test this hypothesis, we sequenced
the entire coding region of KRT12 in selected family mem-
bers. PCR analysis and direct DNA sequencing were performed
in a screening panel of two affected and two unaffected indi-
viduals to determine if there was a mutation within the coding
region of the KRT12 gene that is associated with the form of
MCD found in this family. This analysis identified a novel
heterozygous missense mutation (Arg430Pro; CGC>CCC) in
exon 6 of the KRT12 gene in the affected individuals but not
in the unaffected normal controls of the family (Figure 4A).
Substitution of C for G in codon 430 resulted in the gain of a
recognition site for the restriction enzyme FauI. Since there is
another FauI site 30 bp apart from the site, digestion of the
exon 6 PCR products from patients with this mutation pro-
duced bands of 220, 81, and 30 bp, while normal alleles pro-
duced bands of 220 and 111 bp (Figure 4B). As expected, FauI
digestion of PCR products generated a 81 bp fragment from
the proband but not from his unaffected sister. Therefore, sub-
stitution of C for G in codon 430 is likely associated with
MCD in this family. To determine whether this mutation was
cosegregated with the disease, we examined and compared
the sequence of exon 6 in all DNA samples obtained from the
remaining family members. Sequence analysis showed that
the affected individuals had this mutation but the unaffected
individuals did not (data not shown). To further determine if
this nucleotide substitution were associated with the disease
phenotype, we performed sequence analysis of exon 6 of
KRT12 on the 100 CEPH control individuals. Our goal was to
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Figure 2. Slit-lamp photograph demonstrating discrete microcysts in
the anterior corneal epithelium.  Microcysts ranged from clear vesicles
to opacified inclusions.
Figure 3. Presence of a “peculiar” electron-dense substance in the intraepithelial cysts of the corneal epithelium sampled from the proband.  A:
Electron micrograph of corneal epithelium depicting an intraepithelial cyst containing a “peculiar” electron-dense substance (asterisk) inter-
mixed with small vacuoles and electron-dense filamentous material (original magnification 5,400x). B: Higher magnification of A. The cyst
was bordered by numerous microvillous processes (arrowheads).
977rule out the possibility that this alternation in DNA was a rare
single nucleotide polymorphism occurring in the control popu-
lation. Direct sequencing of exon 6 of the KRT12 gene from
these additional individuals failed to find the same sequence
variation. Therefore, the Arg430Pro mutation that was identi-
fied and was cosegregated with the MCD in this family may
be responsible for MCD of this family.
DISCUSSION
 The family members we examined exhibited an unusually
severe phenotype for MCD characterized by early onset of
the disease, ocular irritation, and poor visual acuity. As an
example, the proband has undergone four phototherapeutic
keratectomy procedures for alleviation of recurrent symptoms.
Irregular astigmatism has been problematic despite the im-
provement of the recurrent corneal erosions. This rather atypi-
cal presentation may reflect the unique Arg430Pro missense
mutation, which lies within the helix termination motif of the
α-helical rod domain of KRT12 (Figure 4B). The helix-termi-
nation motif is highly conserved among keratin proteins and
is critical for keratin fiber formation. In addition to the helix
initiation motif, mutations in this helix-termination motif are
known to result in more severe phenotypes of other inherited
epidermal diseases [18-22]. It is noteworthy that most docu-
mented keratin mutations responsible for MCD are in the he-
lix initiation motif [9-12,14], and a few families have been
identified with a mutation in the helix termination region
[11,13,15,16]. It is possible that the clinical severity observed
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Figure 4. Mutation analysis of the KRT12 gene.  A: Bidirectional sequence analysis of the KRT12 gene. The results shown are in the sense
direction. KRT12 sequence with in the helix-terminal motif of rod domain 2B in affected family members (2 and 3) showing a G to C
transversion at the at the 2nd position of codon 430 that results in an amino acid change from arginine to proline. 1, unaffected father; 2,
affected mother; 3, proband and 4, unaffected sister. B: Restriction endonuclease analysis was used to detect R430P mutation. Amplicons of
exon 6 were digested with FauI, size fractionated on a 2.5% agarose gel, and visualized under ultraviolet light after staining with ethidium
bromide. An additional FauI site (generated by the R430P mutation) converts the 111 bp fragment into 81 and 30 bp fragments. Due to poor
enzyme activity, undigested PCR product (591 bp) was observed. The 30 bp fragment was difficult to visualize. C: The domain structure of
KRT12 and the mutation position found in MCD family in this study is shown. The rod domain comprised four segments (1A, 1B, 2A, and
2B), represented by filled boxes. The helix-initiation and -termination motif are represented by white boxes. The amino acid sequence for the
helix-termination motif is shown.
978in our pedigree is due to the structural change of the keratin
12 protein caused by the replacement of arginine with a pro-
line residue, which is particularly incompatible with an α-he-
lical structure. The amino group of proline imposes both geo-
metric and electrostatic constraints on the α-helix by elimina-
tion of N-Cα bond rotation and available hydrogen bonds. In
contrast, a recent article described an essentially asymptom-
atic family with clinically diagnosed MCD caused by a differ-
ent KRT12 mutation. In this case, the identified KRT12 muta-
tion resulted from a substitution of a nonpolar for another non-
polar amino acid, probably causing a less severe disruption of
the keratin protein structure (and a less severe phenotype) [15].
Unlike other mutations, the Arg430Pro leads to a replace-
ment of a highly charged amino acid with a hydrophobic amino
acid. We believe that the helix-termination motif in the mu-
tant keratin protein may be no longer functional for the fiber
formation. We are unaware of any other reports of KRT12
mutations in MCD with the added instability of a proline sub-
stitution in the helix terminal motif. Our search of Medline,
the Human Gene Mutation Database, or OMIM turned up no
such mutation, although one group reported a proline substi-
tution in the helix terminal motif in KRT3 [17]. We postulate
that the severity of MCD in our pedigree is related specifi-
cally to the biochemical significance of the novel Arg430Pro
mutation described herein.
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